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Abstract: There is conflicting evidence regarding the association between insomnia and the onset of
mild cognitive impairment (MCI) or dementia. This study aimed to evaluate if time-varying insomnia
is associated with the development of MCI and dementia. Data from the Health and Retirement
Study (n = 13,833) from 2002 to 2014 were used (59.4% female). The Brief Insomnia Questionnaire was
used to identify insomnia symptoms which were compiled in an insomnia severity index, ranging
from 0 to 4. In analysis, participants’ symptoms could vary from wave-to-wave. Dementia was
defined using results from the Health and Retirement Study (HRS) global cognitive assessment
tool. Respondents were classified as either having dementia, MCI, or being cognitively healthy. Cox
proportional hazards models with time-dependent exposure using the counting process (start-stop
time) were used for analysis. For each one-unit increase in the insomnia symptom index, there
was a 5-percent greater hazard of MCI (HR = 1.05; 95% CI: 1.04–1.06) and dementia (HR = 1.05;
95% CI: 1.03–1.05), after fully adjusting. Using a nationally representative sample of adults age 51
and older, this study found that time-varying insomnia symptoms are associated with risk of MCI
and dementia. This highlights the importance of identifying sleep disturbances and their change
over time as potentially important risk factors for MCI and dementia.
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1. Introduction
Dementia is a progressive neurodegenerative disorder affecting individuals’ brain
function, memory, and activities of daily living [1]. The prevalence of dementia is expected
to triple in the next 40 years, leading to an estimated 14 million people with dementia
by 2060 [2]. The Alzheimer’s Association estimates the total direct medical expenditures
related to Alzheimer’s disease-related dementias (ADRD) will increase from $236 billion in
2016 to over $1 trillion in 2050 [3].
Mild cognitive impairment (MCI) is defined as self- or informant-reported functional
impairment or impaired test performance on neuropsychological measures that does not
reach the severity of dementia [4]. MCI can be a precursor of dementia [5,6], with over
30 percent of individuals diagnosed with MCI progressing to dementia within five years [1].
MCI is estimated to affect 15–20 percent of older adults in the US [1,7–9]. While there are
several subtypes of MCI with diverse etiology, there is still much debate regarding the
pathogenesis of MCI and dementia [5]. Previous research has identified several modifiable
and immutable factors contributing to an individual’s risk for dementia and MCI including
socio-demographics, comorbidities, family history, and lifestyle factors [1,5,8,10–12].
Growing evidence has linked sleep disturbances and insomnia to greater risk of MCI
and dementia [13–24]. In particular, the association between insomnia, which includes
difficulty falling asleep, awakening during the night, early-awakening without being able
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to fall asleep again, and non-restorative sleep [25], and cognitive decline has received
significant research attention. Results from several studies indicate that individuals with
insomnia are more likely to have clinically significant alterations in attention and episodic
memory and more likely to develop dementia [26–28]. However, very little is known
regarding the frequency or level of insomnia that would result in MCI and dementia.
Published studies examining the associations between insomnia and MCI or dementia
have predominantly assumed insomnia symptoms to be stagnant over time or have not
considered the severity or type of insomnia symptoms [14,17,29–32]. These assumptions
may be especially tenuous among older adult populations, as previous research shows that
insomnia symptoms vary significantly over time and frequently increase as individuals
get older [28]. Further, research suggests that measuring insomnia at only one timepoint
may lead to biased estimates of the associations with MCI and dementia, which may have
important implications for public health and clinical approaches to addressing cognitive
health [31]. Thus, to understand the role of insomnia in the development of MCI and dementia, it is necessary to distinguish chronic insomnia disorder from presence of insomnia
symptoms at a single point in time.
Given the limitations of previous analyses, this study examined the dynamic effect of
changes in insomnia on cognitive decline and dementia over time. Our primary aim was
to estimate the association between time-varying insomnia and MCI or dementia using
a nationally representative cohort of US adults age 51 and older from 2002 to 2014. We
hypothesized that time-varying insomnia symptoms would be associated with greater risk
of incident MCI and dementia.
2. Materials and Methods
2.1. Database
This study used data from the Health and Retirement Study (HRS), a biennial,
population-based survey of older adults in the United States conducted by the University
of Michigan and sponsored by the National Institute on Aging (NIA U01AG009740). HRS
sample collection is based on a multi-stage probability design meant to produce a nationally
representative sample of adults over the age of 50 [33]. Thirty-five sample weights are
provided to account for the complex sampling design and to make inferences regarding
the general US population. Respondents are re-interviewed every two years and asked
questions related to health status, healthcare utilization, cognition, and demographics [33].
The present study used data from seven HRS waves (2002 to 2014). Of individuals who
completed the HRS core survey during the study period, 18,166 adults age 51 and older
provided data on their cognitive status and insomnia symptoms at baseline. We excluded
respondents who were found to have MCI (n = 2996) or dementia (n = 1337) at baseline
leading to the final analytic sample of 13,833 participants who were cognitively healthy
at baseline.
2.2. Outcome Variables
MCI and dementia were assessed at each wave of HRS using a global test of several
cognitive domains, such as working memory, word recall, language, and orientation; the
internal consistency reliability coefficient was about 0.65 [34]. Scores were summed to
a composite score that ranged from 0 to 35 [34]. To determine MCI and dementia, we
used a previously validated classification approach developed using HRS data [35]. The
orientation and language domains were first excluded from the full HRS cognitive score,
yielding a composite score ranging from 0 to 27 [35]. Respondents who scored 0 to 6
were classified as having dementia, those who scored from 7 to 11 were classified as being
cognitively impaired with no dementia (MCI), and respondents scoring from 12 to 27 were
considered not cognitively impaired.

Int. J. Environ. Res. Public Health 2021, 18, 351

3 of 9

2.3. Exposure Variable
Insomnia symptoms were assessed using the Adapted Brief Insomnia Questionnaire
(BIQ) [36]. Trouble falling asleep, waking up during the night, waking up too early and not
being able to fall asleep again most of the time and feeling really rested when you wake up
in the morning rarely or never were considered to be insomnia symptoms. Insomnia was
assessed as a severity score from 0 (no symptoms) to 4 (the most symptoms) [36,37].
2.4. Covariate Variables
Demographic characteristics considered for model adjustment were baseline (wave
2002) age, gender, race, and education. A baseline chronic disease index was calculated by
summing indicators of high blood pressure, diabetes, cancer, lung disease, heart disease,
stroke, psychiatric problems, and arthritis. Additional baseline health information used in
adjustment were body mass index (BMI), smoking status, and number of alcoholic drinks
consumed when drinking. Model covariates were selected based on literature review and
an empirical confounder assessment. If adjustment for a potential confounder produced
at least a 10% change in estimate compared to the crude association, it was kept in the
final model.
2.5. Data Analysis
Descriptive statistics of the baseline sample were calculated with percent and means
for categorical and continuous variables, respectively. Frequencies of self-reported insomnia symptoms and the change from wave-to-wave were calculated and depicted visually
using a Sankey diagram. Adjusted and unadjusted Cox proportional hazards models with
time-dependent exposure were used to estimate the associations between insomnia and
subsequent incidence of MCI or dementia. Specifically, the counting process model, an
extension of the Cox model, was applied to account for the longitudinal information on
insomnia, where the follow-up period was divided into intervals (start and stop time)
based on each wave [38]. Lastly, each model was stratified by baseline age categories (51–64
and 65 and older; effect modification results were not presented since effect modification
by age was not significant) to understand if there was effect modification at baseline by
age. HRS analytic weights and stratification variables were applied to all hazard models to
account for the complex sample design. All analyses were completed with SAS (Statistical
Analysis System) version 9.4 (SAS institute, Cary, NC, USA).
3. Results
3.1. Study Sample Characteristics
The analytic sample included 13,833 participants without MCI or dementia at baseline.
The mean age of participants was 66.41 years (SD = 9.52 years), and 59% were females. A
majority of participants were white (86%) and 17% had less than high school education.
The baseline mean insomnia severity score was 0.58 with a SD of 0.92 (see Table 1). The
Sankey diagram (Figure 1) shows that the percentages of each insomnia symptom category
at each wave were consistent in the period 2002–2006, 2010, and 2014; however, there
was substantial fluctuation of reported insomnia symptoms by individuals from wave-towave. The fluctuation of symptoms suggests that self-reported insomnia symptoms are
time-varying.
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permean
day (SD)
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day (SD)
Smoking
statusper
(%Smoker)
Chronic disease
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(% No(%Smoker)
Chronic illness)
Smoking

Total Sample

Total Sample
= 13,833
N =N13,833

0.58 (0.92)

0.58 (0.92)
66.41
(9.52)
66.41
(9.52)
59.37%
59.37%
86.29%
86.29%
17.25%
17.25%
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Table 2. Unadjusted and adjusted hazard ratios between time-varying insomnia, mild cognitive impairment, and dementia.
Mild Cognitive Impairment

Insomnia
Age (Years)
Education

Race

Gender
Smoking

Less than High School
GED
High School Graduate
Some College
College and Above
White
Black
Other
Male
Female
No
Yes

BMI
Number of
Chronic Diseases
Number of Drinks

Dementia

Unadjusted

Adjusted *

Unadjusted

Adjusted *

1.10 ˆ (1.09–1.11)

1.05 ˆ (1.04–1.06)
1.06 ˆ (1.06–1.06)

1.09 ˆ (1.07–1.10)

1.05 ˆ (1.03–1.06)
1.11 ˆ (1.11–1.11)

3.60 ˆ (3.59–3.60)
2.42 ˆ (2.42–2.43)
2.03 ˆ (2.02–2.03)
1.53 ˆ (1.53–1.53)
Ref
Ref
1.95 ˆ (1.95–1.95)
1.62 ˆ (1.61–1.62)
Ref
0.81 ˆ (0.81–0.81)
Ref
1.25 ˆ (1.24–1.25)
1.00 (0.99–1.00)

2.67 ˆ (2.66–2.68)
1.84 ˆ (1.83–1.84)
1.48 ˆ (1.47–1.48)
1.19 ˆ (1.19–1.20)
Ref
Ref
2.09 ˆ (2.08–2.10)
1.61 ˆ (1.60–1.62)
Ref
0.98 ˆ (0.98–0.98)
Ref
1.36 ˆ (1.36–1.37)
0.98 ˆ (0.98–0.98)

1.08 ˆ (1.08–1.08)

1.59 ˆ (1.59–1.59)

0.96 ˆ (0.96–0.96)

0.91 ˆ (0.91–0.92)

Note: * adjusted for baseline age, gender, race, education, body mass index, drinking, smoking status, and chronic disease index;
ˆ p-value < 0.05.

4. Discussion
Using a nationally representative sample of adults age 51 and older, this study found
that time-varying insomnia severity was associated with a greater likelihood of developing
MCI and dementia over time. In support of our hypothesis, over 12 years of followup, results suggested that for each additional insomnia symptom, there was a 5 percent
greater hazard of incident MCI (HR = 1.05; 95% CI: 1.04–1.06) and dementia (HR = 1.05;
95% CI: 1.03–1.06), after adjusting for baseline gender, race, education, BMI, smoking status,
drinking status, and chronic disease index.
Previous research regarding the associations between insomnia and MCI/dementia
are mixed and sometimes contradictory. For instance, Hung et al. (2018) found that
insomnia was associated with a 2.14 times greater dementia risk [28]. Conversely, Lysen
et al. (2018) found that sleep quality was not associated with incident dementia (HR: 0.91;
95% CI: 0.82–1.02) [39]; however, these studies used different sleep measures and different
study designs and did not account for time-varying insomnia symptoms, which may
explain inconsistent results. Our findings are consistent with a positive association between
insomnia and greater risk of incident cognitive decline and dementia. The degree of risk is
similar to that found in a meta-analysis by Xu et al. (2020) [23].
Differences between our study and previously conducted studies with different or
null findings could be related to several methodologic and sample differences. Our study
used a longitudinal study design with time-varying insomnia, while other studies have
used cross-sectional [23] or case-control [28] study design or assessed insomnia only at
baseline [39]. Additionally, we considered insomnia symptoms on a continuous scale
while other studies used clinical diagnosis [28] or categorical insomnia definitions [23].
Consistent with previous research, our results demonstrate that insomnia symptoms vary
significantly over time [40,41]. The use of time-invariant insomnia symptoms in analysis
may thus fail to distinguish the effects of chronic insomnia from more transient insomnia
episodes, for instance due to illness or use of medications. Previous research shows that
a significant proportion of people with transient insomnia might not develop chronic
insomnia and the consequences of transient insomnia may be subtle [42]. In contrast,
chronic insomnia has been associated with a wide range of deleterious health consequences
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including an increased risk of hypertension, diabetes, obesity, depression, heart attack, and
stroke, [28,43], which are also related to risk of cognitive decline and dementia. Information
about the duration and changing severity of insomnia may thus provide more information
about the cumulative effects of insomnia, both directly and indirectly, on cognition.
Several potential mechanisms have been proposed to explain how insomnia may
increase risk of MCI and dementia. First, poor sleep—as defined by insomnia, sleep
duration, sleep quality, intake of hypnotics, and sleep-disorder related to breathing—has
been shown to be associated with neuronal degradation, structural changes of the brain
and lower brain volumes [44,45]. A recent review by Joo (2015) found that insomnia may be
associated with abnormal brain structures in the frontal cortex, hippocampus, and anterior
cingulate cortex, areas important for memory, executive functions and other cognitive
domains. These changes were due to a decrease in gray matter volumes in key regions
associated with cognitive function [44]. More specifically, the researchers found evidence
of greater atrophy among those with insomnia compared to controls in the CA2-4-DG
region of the hippocampus, which was associated with impairment in verbal information
processing, verbal memory, verbal processing, and visual memory [45]. Additional studies
have found that insomnia symptoms in aging populations are independently associated
with neuronal loss in the hippocampus [46]. During healthy sleep, the human brain
clears amyloid-beta (Aβ) peptide accumulated during wake phases via the glymphatic
pathway [47,48]. Sleep disturbances may thus interrupt or hamper this process resulting in
an accumulation of Aβ in the brain, a hallmark of AD pathogenesis [49]. Alternatively, some
research suggests that there may be a bidirectional association between sleep disturbances,
MCI and dementia [49–51]. This bidirectional association may suggest that preclinical MCI
or dementia may be influencing the development of insomnia followed by the development
of detectable cognitive problems. Further, several modifiable and immutable factors, such
as socio-demographics, comorbidities, family history, and lifestyle factors, are associated
with insomnia, and over time, can lead to cognitive problems, including dementia and
MCI [1,5,8,10–12].
The current study has many strengths, including a large sample size, 12-year followup, and use of a representative sample of adults age 51 and over in the United States;
however, there are some limitations to note. First, insomnia symptoms were self-reported
from the BIQ questionnaire and were compiled into an unweighted linear symptom index
assuming equal weighting of all symptoms. Additionally, we were unable to confirm a
clinical diagnosis of insomnia. Second, both outcome variables relied on cognitive and
neuropsychological tests. Using imaging methods and/or clinical diagnosis of MCI and
dementia could have led to different estimates of the association with insomnia. Last, this
study did not differentiate between types of dementias which and cannot be interpreted in
the light of specific forms of dementia, just an overall assessment. Future research should
focus on understanding how time-varying insomnia is differentially associated with MCI
and dementia compared to baseline or time-invariant insomnia. Additionally, it should
be understood whether time-variant insomnia is associated with structural brain changes
similar to those found in previous research.
5. Conclusions
In conclusion, this study showed that participants with more insomnia symptoms
had an increased risk of MCI and dementia. The current results, in conjunction with
other studies, highlight the importance of identifying sleep disturbances as a potentially
important risk factor for the development of MCI and dementia. It is especially important
for primary care providers to assess their patients’ risk of sleep problems, as they may be
able to intervene to prevent or delay the onset of MCI or dementia through lifestyle changes
(e.g., more exercise or less coffee and alcohol) and behavioral therapy. Future studies
should identify the association between fluctuating insomnia symptoms and specific forms
of dementia.
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